Gut microbiota and probiotics in colon tumorigenesis

Cancer Letters

Volumn 309, Issue 2, 2011, Pages 119-127

  Zhu, Yuanmin ^a   Michelle Luo, T ^c   Jobin, Christian ^b   Young, Howard A ^d  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c CENTER FOR DEVICES AND RADIOLOGICAL HEALTH   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Colorectal cancer; Inflammation; Microbiota; Probiotics

Indexed keywords

BETA DEFENSIN 2; GAMMA INTERFERON; INTERLEUKIN 12; MUCIN 2; NONSTEROID ANTIINFLAMMATORY AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT; REACTIVE OXYGEN METABOLITE; SYNBIOTIC AGENT; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; VSL3; YOGHURT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; CANCER INCIDENCE; CANCER RISK; CANCER SUSCEPTIBILITY; CD4+ T LYMPHOCYTE; COLON CANCER; COLON CARCINOGENESIS; COLORECTAL CANCER; COLORECTAL TUMOR; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; ENTERITIS; ENZYME INHIBITION; HOST PATHOGEN INTERACTION; HUMAN; ILEITIS; IMMUNOMODULATION; INTESTINE FLORA; LACTIC ACID BACTERIUM; LACTOBACILLUS CASEI; LACTOBACILLUS JOHNSONII; LACTOBACILLUS RHAMNOSUS; LIPID DIET; MICROSATELLITE INSTABILITY; MUCOSA INFLAMMATION; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROPIONIBACTERIUM FREUDENREICHII SHERMANII; PROTEIN DIET; RISK FACTOR; SHORT SURVEY; STREPTOCOCCUS THERMOPHILUS;

EUKARYOTA;

EID: 79960848579     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.004     Document Type: Review

References (76)

1. Whitman William William B., Coleman David C., Wiebe William J. Prokaryotes: the unseen majority. Proc. Natl. Acad. Sci. USA 1998, 95:6578-6583. (PubMed: 9618454).
2. Orrhage K., Nord C.E. Factors controlling the bacterial colonization of the intestine in breast fed infants. Acta Paediatr. Suppl. 1999, 88:47-57. (PubMed: 10569223).
3. Biasucci G., Rubini M., Riboni S., Retetangos C., Morelli L., Bessi E. Mode of delivery affects the bacterial community in the newborn gut. Early Hum. Dev. 2010, 86(Suppl. 1):13-15. (PubMed: 20133091).
4. Rubaltelli F.F., Biadaioli R., Pecile P., Nicoletti P. Intestinal flora in breast- and bottle-fed infants. J. Perinat. Med. 1998, 26:186-191. (PubMed: 9773376).
5. Kalliomaki M., Kirjavainen P., Eerola E., Kero P., Salminen S., Isolauri E. Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J. Allergy Clin. Immunol. 2001, 107:129-134. (PubMed: 11150002).
6. Ouwehand A.C., Isolauri E., He F., Hashimoto H., Benno Y., Salminen S. Differences in Bifidobacterium flora composition in allergic and healthy infants. J. Allergy Clin. Immunol. 2001, 108:144-145. (PubMed: 11447399).
7. De Filippo C., Cavalieri D., Di Paola M., Ramazzotti M., Poullet J.B., Massart S., Collini S., Pieraccini G., Lionetti P. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. USA 2010, 107:14691-14696. (PubMed: 20679230).
8. Farrokhyar F., Swarbrick E.T., Irvine E.J. A critical review of epidemiological studies in inflammatory bowel disease. Scand. J. Gastroenterol. 2001, 36:2-15. (PubMed: 11218235).
9. Tennyson C.A., Friedman G. Microecology, obesity, and probiotics. Curr. Opin. Endocrinol. Diabetes Obes. 2008, 15:422-427. (PubMed: 18769213).
10. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005, 55:74-108. (PubMed: 15761078).
11. Ferlay J., Bray F., Pisani P., Parkin D.M. Globocan 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC Cancer Base No. 5 Version 2.0 2004, IARC Press, Lyon, France.
12. Chambers W.M., Warren B.F., Jewell D.P., Mortensen N.J. Cancer surveillance in ulcerative colitis. Br. J. Surg. 2005, 92:928-936. (PubMed: 16034807).
13. Sobhani I., Tap J., Roudot-Thoraval F., Roperch J.P., Letulle S., Langella P., Corthier G., Van Nhieu J.T., Furet J.P. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011, 6:e16393. (PubMed: 21297998).
14. Shen X.J., Rawls J.F., Randall T., Burcal L., Mpande C.N., Jenkins N., Jovov B., Abdo Z., Sandler R.S., Keku T.O. Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas. Gut Microbes 2010, 1:138-147. (PubMed: 20740058).
15. Mäkivuokko H., Tiihonen K., Tynkkynen S., Paulin L., Rautonen N. The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br. J. Nutr. 2010, 103:227-234. (PubMed: 19703328).
16. Enck P., Zimmermann K., Rusch K., Schwiertz A., Klosterhalfen S., Frick J.S. The effects of ageing on the colonic bacterial microflora in adults. Z Gastroenterol. 2009, 47:653-658. (PubMed: 19606407).
17. O'Keefe S.J., Ou J., Aufreiter S., O'Connor D., Sharma S., Sepulveda J., Fukuwatari T., Shibata K., Mawhinney T. Products of the colonic microbiota mediate the effects of diet on colon cancer risk. J. Nutr. 2009, 139:2044-2048. (PubMed: 19741203).
18. O'Keefe S.J., Chung D., Mahmoud N., Sepulveda A.R., Manafe M., Arch J., Adada H., van der Merwe T. Why do African Americans get more colon cancer than native Africans?. J. Nutr. 2007, 137(Suppl. 1):S175-182. (PubMed: 17182822).
19. Collado M.C., Isolauri E., Laitinen K., Salminen S. Effect of mother's weight on infant's microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am. J. Clin. Nutr. 2010, 92:1023-1030. (PubMed: 20844065).
20. Shida K., Kiyoshima-Shibata J., Nagaoka M., Watanabe K., Nanno M. Induction of interleukin-12 by Lactobacillus strains having a rigid cell wall resistant to intracellular digestion. J. Dairy Sci. 2006, 89:3306-3317. (PubMed: 16899663).
21. Roller M., Pietro Femia A., Caderni G., Rechkemmer G., Watzl B. Intestinal immunity of rats with colon cancer is modulated by oligofructose-enriched inulin combined with Lactobacillus rhamnosus and Bifidobacterium lactis. Br. J. Nutr. 2004, 92:931-938. (PubMed: 15613255).
22. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023. (PubMed: 17183309).
23. Kalliomäki M., Collado M.C., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am. J. Clin. Nutr. 2008, 87:534-538. (PubMed: 18326589).
24. Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA 2004, 101:15718-15723. (PubMed: 15505215).
25. Bischoff S.C. 'Gut health': a new objective in medicine?. BMC Med. 2011, 9:24. (PubMed: 21401922).
26. Preidis G.A., Versalovic J. Targeting the human microbiome with antibiotics, probiotics, and prebiotics: gastroenterology enters the metagenomics era. Gastroenterology 2009, 136:2015-2031. (PubMed: 19462507).
27. Duerkop B.A., Vaishnava S., Hooper L.V. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009, 31:368-376. (PubMed: 19766080).
28. Wehkamp J., Fellermann K., Herrlinger K.R., Bevins C.L., Stange E.F. Mechanisms of disease: defensins in gastrointestinal diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2005, 2:406-415. (PubMed: 16265431).
29. Andrianifahanana M., Moniaux N., Batra S.K. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. Biochim. Biophys. Acta 2006, 1765(2):189-222. (PubMed: 16487661).
30. Yang K., Popova N.V., Yang W.C., Lozonschi I., Tadesse S., Kent S., Bancroft L., Matise I., Cormier R.T., Scherer S.J., Edelmann W., Lipkin M., Augenlicht L., Velcich A. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation. Cancer Res. 2008, 68(18):7313-7322. (PubMed: 18794118).
31. Vaishnava S., Behrendt C.L., Ismail A.S., Eckmann L., Hooper L.V. Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface. Proc. Natl. Acad. Sci. USA 2008, 105(52):20858-20863. (PubMed: 19075245).
32. Schneider M.R., Dahlhoff M., Horst D., Hirschi B., Trülzsch K., Müller-Höcker J., Vogelmann R., Allgäuer M., Gerhard M., Steininger S., Wolf E., Kolligs F.T. A key role for E-cadherin in intestinal homeostasis and Paneth cell maturation. PLoS One 2010, 5:e14325. (PubMed: 21179475).
33. Sprong R.C., Schonewille A.J., van der Meer R. Dietary cheese whey protein protects rats against mild dextran sulfate sodium-induced colitis: role of mucin and microbiota. J. Dairy Sci. 2010, 93:1364-1371. (PubMed: 20338413).
34. Cinova J., De Palma G., Stepankova R., Kofronova O., Kverka M., Sanz Y., Tuckova L. Role of intestinal bacteria in gliadin-induced changes in intestinal mucosa: study in germ-free rats. PLoS One 2011, 6:e16169. (PubMed: 21249146).
35. Swidsinski A., Khilkin M., Kerjaschki D., Schreiber S., Ortner M., Weber J., Lochs H. Association between intraepithelial Escherichia coli and colorectal cancer. Gastroenterology 1998, 115:281-286. (PubMed: 9679033).
36. Burn J., Bishop D.T., Mecklin J.P., Macrae F., Möslein G., Olschwang S., Bisgaard M.L., Ramesar R., Eccles D., Maher E.R., Bertario L., Jarvinen H.J., Lindblom A., Evans D.G., Lubinski J., Morrison P.J., Ho J.W., Vasen H.F., Side L., Thomas H.J., Scott R.J., Dunlop M., Barker G., Elliott F., Jass J.R., Fodde R., Lynch H.T. CAPP2 Investigators. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl. J. Med. 2008, 359:2567-2578. (PubMed: 19073976).
37. Goel A., Mittal A., Evstatiev R., Nemeth M., Kruis W., Stolte M., Boland C.R., Gasche C. In vivo effects of mesalazine or E. coli Nissle 1917 on microsatellite instability in ulcerative colitis. Aliment Pharmacol. Ther. 2009, 30:634-642. (PubMed: 19558562).
38. Moran J.P., Walter J., Tannock G.W., Tonkonogy S.L., Sartor R.B. Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice. Inflamm. Bowel Dis. 2009, 15:1022-1031. (PubMed: 19235917).
39. Wu S., Rhee K.J., Albesiano E., Rabizadeh S., Wu X., Yen H.R., Huso D.L., Brancati F.L., Wick E., McAllister F., Housseau F., Pardoll D.M., Sears C.L. A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses. Nat. Med. 2009, 15:1016-1022. (PubMed: 19701202).
40. Joshua M., Uronis J.M., Mühlbauer M., Herfarth H.H., Rubinas T.C., Jones G.S., Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 2009, 4:e6026. (PubMed: 19551144).
41. Chen G.Y., Shaw M.H., Redondo G., Núñez G. The innate immune receptor Nod1 protects the intestine from inflammation-induced tumorigenesis. Cancer Res. 2008, 68:10060-10067. (PubMed: 19074871).
42. Allen I.C., TeKippe E.M., Woodford R.M., Uronis J.M., Holl E.K., Rogers A.B., Herfarth H.H., Jobin C., Ting J.P. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 2010, 207:1045-1056. (PubMed: 20385749).
43. S. Normand, A. Delanoye-Crespin, A. Bressenot, L. Huot, T. Grandjean, L. Peyrin-Biroulet, Y. Lemoine, D. Hot, M. Chamaillard, Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury, Proc. Natl. Acad. Sci. USA, 2011 (May 18, Epub. ahead of print, PubMed PMID: 21593405).
44. Wald D., Qin J., Zhao Z., Qian Y., Naramura M., Tian L., Towne J., Sims J.E., Stark G.R., Li X. SIGIRR, a negative regulator of toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 2003, 4:920-927. (PubMed: 12925853).
45. Xiao H., Gulen M.F., Qin J., Yao J., Bulek K., Kish D., Altuntas C.Z., Wald D., Ma C., Zhou H., Tuohy V.K., Fairchild R.L., de la Motte C., Cua D., Vallance B.A., Li X. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis. Clin. Exp. Immunol. Immun. 2007, 26:461-475. (PubMed: 17398123).
46. Kadota C., Ishihara S., Aziz M.M., Rumi M.A., Oshima N., Mishima Y., Moriyama I., Yuki T., Amano Y., Kinoshita Y. Down-regulation of single immunoglobulin interleukin-1R-related molecule (SIGIRR)/TIR8 expression in intestinal epithelial cells during inflammation and tumorigenesis. Clin. Exp. Immunol. 2010, 162:348-361. (PubMed: 21077278).
47. Gong J., Wei T., Stark R.W., Jamitzky F., Heckl W.M., Anders H.J., Lech M., Rössle S.C. Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: a computational approach. J. Struct. Biol. 2010, 169:323-330. (PubMed: 20025973).
48. Salcedo R., Worschech A., Cardone M., Jones Y., Gyulai Z., Dai R.M., Wang E., Ma W., Haines D., O'huigin C., Marincola F.M., Trinchieri G. MyD88-mediated signaling prevents development of adenocarcinomas of the colon: role of interleukin 18. J. Exp. Med. 2010, 207:1625-1636. (PubMed: 20624890).
49. Fukata M., Chen A., Vamadevan A.S., Cohen J., Breglio K., Krishnareddy S., Hsu D., Xu R., Harpaz N., Dannenberg A.J., Subbaramaiah K., Cooper H.S., Itzkowitz S.H., Abreu M.T. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007, 133:1869-1881. (PubMed: 18054559).
50. González-Navajas J.M., Fine S., Law J., Datta S.K., Nguyen K.P., Yu M., Corr M., Katakura K., Eckman L., Lee J., Raz E. TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice. J. Clin. Invest. 2010, 120:570-581. (PubMed: 20051628).
51. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria. Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria, October 2001. http://www.who.int/entity/foodsafety/publications/fs_management/en/probiotics.pdf.
52. K.C. Anukam, G. Reid, Probiotics: 100years (1907-2007) After Elie Metchnikoff's observations, in: A. Mendez-Vilas (Ed.), Communicating Current Research and Educational Topics and Trends in Applied Microbiology, Formatex.org, Spain, 2007, pp. 466-474.
53. Capurso G., Marignani M., Delle Fave G. Probiotics and the incidence of colorectal cancer: when evidence is not evident. Dig. Liver Dis. 2006, 38(Suppl. 2):S277-S282. (PubMed: 17259091).
54. Orlando A., Messa C., Linsalata M., Cavallini A., Russo F. Effects of Lactobacillus rhamnosus GG on proliferation and polyamine metabolism in HGC-27 human gastric and DLD-1 colonic cancer cell lines. Immunopharmacol. Immunotoxicol. 2009, 31:108-116. (PubMed: 19234959).
55. Lee N.K., Park J.S., Park E., Paik H.D. Adherence and anticarcinogenic effects of Bacillus polyfermenticus SCD in the large intestine. Lett. Appl. Microbiol. 2007, 44:274-278. (PubMed: 17309504).
56. Kim Y., Lee D., Kim D., Cho J., Yang J., Chung M., Kim K., Ha N. Inhibition of proliferation in colon cancer cell lines and harmful enzyme activity of colon bacteria by Bifidobacterium adolescentis SPM0212. Arch. Pharm. Res. 2008, 31:467-468. (PubMed: 18449504).
57. Paolillo R., Romano Carratelli C., Sorrentino S., Mazzola N., Rizzo A. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int. Immunopharmacol. 2009, 9:1265-1271. (PubMed: 19647100).
58. Perdigón G., Valdez J.C., Rachid M. Antitumour activity of yogurt: study of possible immune mechanisms. J. Dairy Res. 1998, 65:129-138. (PubMed: 9513059).
59. Urbanska A.M., Bhathena J., Martoni C., Prakash S. Estimation of the potential antitumor activity of microencapsulated Lactobacillus acidophilus yogurt formulation in the attenuation of tumorigenesis in Apc(Min/+) mice. Dig. Dis. Sci. 2009, 54:264-273. (PubMed: 18633708).
60. Pagnini C., Saeed R., Bamias G., Arseneau K.O., Pizarro T.T., Cominelli F. Probiotics promote gut health through stimulation of epithelial innate immunity. Proc. Natl. Acad. Sci. USA 2010, 107:454-459. (PubMed: 20018654).
61. de Moreno de Leblanc A., Perdigón G. Yogurt feeding inhibits promotion and progression of experimental colorectal cancer. Med. Sci. Monit. 2004, 10:BR96-BR104. (PubMed: 15039638).
62. Lin P.W., Myers L.E., Ray L., Song S.C., Nasr T.R., Berardinelli A.J., Kundu K., Murthy N., Hansen J.M., Neish A.S. Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic. Biol. Med. 2009, 47(8):1205-1211. (PubMed: 19660542).
63. Dolara P., Luceri C., De Filippo C., Femia A.P., Giovannelli L., Caderni G., Cecchini C., Silvi S., Orpianesi C., Cresci A. Red wine polyphenols influence carcinogenesis, intestinal microflora, oxidative damage and gene expression profiles of colonic mucosa in F344 rats. Mutat. Res. 2005, 591:237-246. (PubMed: 16293270).
64. Park E., Jeon G.I., Park J.S., Paik H.D. A probiotic strain of Bacillus polyfermenticus reduces DMH induced precancerous lesions in F344 male rat. Biol. Pharm. Bull. 2007, 30:569-574. (PubMed: 17329858).
65. Pagnini C., Corleto V.D., Hoang S.B., Saeed R., Cominelli F., Delle Fave G. Commensal bacteria and " Oncologic Surveillance" suggestions from an experimental model. J. Clin. Gastroenterol. 2008, 42(Suppl. 3, Pt. 2):S193-S196. (PubMed: 18685507).
66. Mai V., Colbert L.H., Perkins S.N., Schatzkin A., Hursting S.D. Intestinal microbiota: a potential diet-responsive prevention target in ApcMin mice. Mol. Carcinog. 2007, 46:42-48. (PubMed: 16929480).
67. Le Leu R.K., Hu Y., Brown I.L., Woodman R.J., Young G.P. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis 2010, 31:246-251. (PubMed: 19696163).
68. Veiga P., Gallini C.A., Beal C., Michaud M., Delaney M.L., DuBois A., Khlebnikov A., van Hylckama Vlieg J.E., Punit S., Glickman J.N., Onderdonk A., Glimcher L.H., Garrett W.S. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc. Natl. Acad. Sci. USA 2010, 107(42):18132-18137. (PMID: 20921388).
69. Fuhrer A., Sprenger N., Kurakevich E., Borsig L., Chassard C., Hennet T. Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J. Exp. Med. 2010, 207(13):2843-2854. (PMID: 21098096).
70. Lara-Villoslada F., de Haro O., Camuesco D., Comalada M., Velasco J., Zarzuelo A., Xaus J., Galvez J. Short-chain fructooligosaccharides, in spite of being fermented in the upper part of the large intestine, have anti-inflammatory activity in the TNBS model of colitis. Eur. J. Nutr. 2006, 45:418-425. (PubMed: 16871370).
71. Guidelines for the Evaluation of Probiotics in Food: Joint FAO/WHO Working Group Meeting, London, Ontario, Canada, 2002 (30 April-1 May).
72. Ishikawa H., Akedo I., Otani T., Suzuki T., Nakamura T., Takeyama I., Ishiguro S., Miyaoka E., Sobue T., Kakizoe T. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. Int. J. Cancer 2005, 116:762-767. (PubMed: 15828052).
73. Rafter J., Bennett M., Caderni G., Clune Y., Hughes R., Karlsson P.C., Klinder A., O'Riordan M., O'Sullivan G.C., Pool-Zobel B., Rechkemmer G., Roller M., Rowland I., Salvadori M., Thijs H., Van Loo J., Watzl B., Collins J.K. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am. J. Clin. Nutr. 2007, 85:488-496. (PubMed: 17284748).
74. Hatakka K., Holma R., El-Nezami H., Suomalainen T., Kuisma M., Saxelin M., Poussa T., Mykkänen H., Korpela R. The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. Int. J. Food Microbiol. 2008, 128:406-410. (PubMed: 18945506).
75. Gianotti Luca, Morelli Lorenzo, Galbiati Francesca, Rocchetti Simona, Coppola Sara, Beneduce Aldo, Gilardini Cristina, Zonenschain Daniela, Nespoli Angelo, Braga Marco A randomized double-blinded trial on perioperative administration of probiotics in colorectal cancer patients. World J. Gastroenterol. 2010, 16:167-175. (PubMed: 20066735).
76. V. Pala, S. Sieri, F. Berrino, P. Vineis, C. Sacerdote, D. Palli, G. Masala, S. Panico, A. Mattiello, R. Tumino, M.C. Giurdanella, C. Agnoli, S. Grioni, V. Krogh, Yogurt consumption and risk of colorectal cancer in the italian EPIC cohort, Int. J. Cancer, 2011, (May 23, Epub ahead of print, PMID: 21607947). doi:10.1002/ijc.26193.